RGT 4.48% 35.0¢ argent biopharma limited

Ann: Cannabinoid Extraction Facility On Target Q2 Production, page-15

  1. 1,078 Posts.
    lightbulb Created with Sketch. 122
    Winner you are a holder right? You are saying none of the below points off top of head have the potential to raise the SP over the coming 6 months? In spite of current SP being 20% lower than a a point last year where there were more variables and the company was not as far down the track?

    - CBD extraction facility build completion
    - Production of first propriety research grade product in newly owned / run labs
    - Progression through phases of commenced epilepsy trial
    - Update on derma clin trials currently in progress re flaky skin etc
    - More derma sales
    - More grow-ops / crop growth via panax updates etc
    - Potential update to Australian license app

    There is a lot tangible activity to track over the coming months that has the potential to pave the way for this company to be a real player in what is a growing industry.

    Either you are morbidly negative and stressing hard or or you have other motives ...

    Pretty shocked re the negativity in here - MXC are making progress and communicating...something they needed to improve and are clearly taking on board. Can't see so much as an angle for negativity here. If SP was floating around 6 cents it would be a different song...
    Last edited by daphil_1: 20/02/17
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
0.015(4.48%)
Mkt cap ! $16.94M
Open High Low Value Volume
34.5¢ 35.5¢ 33.0¢ $60.95K 174.5K

Buyers (Bids)

No. Vol. Price($)
2 11855 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 1338 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.